FARAJ PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FARAJ PHARMA
Largest movements
- Cash +€10,598
up €10,598 (+23.0%), from €46,010 to €56,609
mainly Net result for the year (+€31,332) and Receivables within one year (+€2,792)
- Stocks and contracts +€4,714
up €4,714 (+17.4%), from €27,056 to €31,769
- Receivables within one year -€2,792
down €2,792 (-7.1%), from €39,161 to €36,369
of which Other amounts receivable: -€8,157
- Profit (loss) carried forward +€21,332
up €21,332 (+364.7%), from €5,850 to €27,182
- Other debts -€3,647
down €3,647 (-8.1%), from €45,000 to €41,353
- Tax, wage and social debts -€2,900
down €2,900 (-75.9%), from €3,823 to €923
- Trade debts -€2,666
down €2,666 (-6.4%), from €41,554 to €38,888
- Gross operating margin +€1,090
up €1,090 (+2.5%), from €43,184 to €44,273
- Financial charges -€694
down €694 (-20.7%), from €3,345 to €2,651
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €116,686 | €128,805 | +€12,119 | +10.4% |
| Fixed assets | 21/28 | €2,182 | €3,059 | +€878 | +40.2% |
| Tangible fixed assets | 22/27 | €2,182 | €3,059 | +€878 | +40.2% |
| Plant, machinery and equipment | 23 | €186 | €2,356 | +€2,170 | +1166.1% |
| Furniture and vehicles | 24 | €1,995 | €703 | -€1,292 | -64.7% |
| Current assets | 29/58 | €114,505 | €125,746 | +€11,241 | +9.8% |
| Stocks and contracts in progress | 3 | €27,056 | €31,769 | +€4,714 | +17.4% |
| Stocks | 30/36 | €27,056 | €31,769 | +€4,714 | +17.4% |
| Amounts receivable within one year | 40/41 | €39,161 | €36,369 | -€2,792 | -7.1% |
| Trade receivables | 40 | €30,680 | €36,045 | +€5,366 | +17.5% |
| Other amounts receivable | 41 | €8,481 | €324 | -€8,157 | -96.2% |
| Cash at bank and in hand | 54/58 | €46,010 | €56,609 | +€10,598 | +23.0% |
| Deferred charges and accrued income | 490/1 | €2,278 | €998 | -€1,280 | -56.2% |
| Total equity and liabilities | 10/49 | €116,686 | €128,805 | +€12,119 | +10.4% |
| Equity | 10/15 | €26,310 | €47,642 | +€21,332 | +81.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €5,850 | €27,182 | +€21,332 | +364.7% |
| Amounts payable | 17/49 | €90,377 | €81,163 | -€9,213 | -10.2% |
| Amounts payable within one year | 42/48 | €90,377 | €81,163 | -€9,213 | -10.2% |
| Trade debts | 44 | €41,554 | €38,888 | -€2,666 | -6.4% |
| Suppliers | 440/4 | €41,554 | €38,888 | -€2,666 | -6.4% |
| Taxes, remuneration and social security | 45 | €3,823 | €923 | -€2,900 | -75.9% |
| Taxes | 450/3 | €3,823 | €923 | -€2,900 | -75.9% |
| Other amounts payable | 47/48 | €45,000 | €41,353 | -€3,647 | -8.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,928 | €1,634 | -€293 | -15.2% |
| Other operating charges | 640/8 | €0 | - | -€0 | |
| Gross operating margin | 9900 | €43,184 | €44,273 | +€1,090 | +2.5% |
| Operating profit (loss) | 9901 | €41,256 | €42,639 | +€1,383 | +3.4% |
| Financial income | 75/76B | €24 | €20 | -€4 | -16.8% |
| Recurring financial income | 75 | €24 | €20 | -€4 | -16.8% |
| Financial charges | 65/66B | €3,345 | €2,651 | -€694 | -20.7% |
| Recurring financial charges | 65 | €3,345 | €2,651 | -€694 | -20.7% |
| Profit (loss) for the period before taxes | 9903 | €37,935 | €40,008 | +€2,073 | +5.5% |
| Income taxes | 67/77 | €8,587 | €8,676 | +€89 | +1.0% |
| Profit (loss) for the period | 9904 | €29,348 | €31,332 | +€1,984 | +6.8% |
| Profit (loss) for the period to be appropriated | 9905 | €29,348 | €31,332 | +€1,984 | +6.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.